You need to sign in or sign up before continuing.
Epilepsy research
-
Randomized Controlled Trial Clinical Trial
Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy.
To evaluate the long-term clinical usefulness of levetiracetam (LEV, Keppra((R))(1)) as add-on therapy in patients with refractory epilepsy. ⋯ LEV offers sustained efficacy in patients with refractory partial seizures, and its long-term tolerability is similar to that seen in the short-term placebo-controlled trials.